OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
Solène M. Laville, Ziad A. Massy, Saïd Kamel, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 91-91
Open Access | Times Cited: 15
Solène M. Laville, Ziad A. Massy, Saïd Kamel, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 91-91
Open Access | Times Cited: 15
Showing 15 citing articles:
Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?
Sophie Liabeuf, Marion Pépin, Casper Franssen, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. Supplement_2, pp. ii33-ii44
Open Access | Times Cited: 60
Sophie Liabeuf, Marion Pépin, Casper Franssen, et al.
Nephrology Dialysis Transplantation (2021) Vol. 37, Iss. Supplement_2, pp. ii33-ii44
Open Access | Times Cited: 60
Uremic encephalopathy
Mitchell H. Rosner, Faeq Husain‐Syed, Thiago Reis, et al.
Kidney International (2021) Vol. 101, Iss. 2, pp. 227-241
Closed Access | Times Cited: 44
Mitchell H. Rosner, Faeq Husain‐Syed, Thiago Reis, et al.
Kidney International (2021) Vol. 101, Iss. 2, pp. 227-241
Closed Access | Times Cited: 44
Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
Carolla El Chamieh, Sophie Liabeuf, Ziad Massy
Toxins (2022) Vol. 14, Iss. 4, pp. 280-280
Open Access | Times Cited: 37
Carolla El Chamieh, Sophie Liabeuf, Ziad Massy
Toxins (2022) Vol. 14, Iss. 4, pp. 280-280
Open Access | Times Cited: 37
Gut-derived uremic toxins and cardiovascular health in chronic kidney disease
Ming‐Chun Chen, Chiu‐Huang Kuo, Yu‐Li Lin, et al.
Tzu Chi Medical Journal (2025)
Open Access
Ming‐Chun Chen, Chiu‐Huang Kuo, Yu‐Li Lin, et al.
Tzu Chi Medical Journal (2025)
Open Access
Oral Absorbent AST-120 Is Associated with Compositional and Functional Adaptations of Gut Microbiota and Modification of Serum Short and Medium-Chain Fatty Acids in Advanced CKD Patients
Cheng-Kai Hsu, Shih‐Chi Su, Lun‐Ching Chang, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2234-2234
Open Access | Times Cited: 13
Cheng-Kai Hsu, Shih‐Chi Su, Lun‐Ching Chang, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2234-2234
Open Access | Times Cited: 13
Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis
Xiaojun Li, Qiyuan Shan, X. Wu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Xiaojun Li, Qiyuan Shan, X. Wu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Derivation and elimination of uremic toxins from kidney-gut axis
Ying Xu, Wen-Di Bi, Yu-Xuan Shi, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 6
Ying Xu, Wen-Di Bi, Yu-Xuan Shi, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 6
Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification
Yan Rong, Tony K. L. Kiang
Toxicology and Applied Pharmacology (2021) Vol. 425, pp. 115553-115553
Closed Access | Times Cited: 9
Yan Rong, Tony K. L. Kiang
Toxicology and Applied Pharmacology (2021) Vol. 425, pp. 115553-115553
Closed Access | Times Cited: 9
Role of uremic toxins in vascular disease—the end of nihilism?
Ziad A. Massy, Tilman B. Drüeke
Kidney International (2022) Vol. 101, Iss. 6, pp. 1100-1102
Closed Access | Times Cited: 4
Ziad A. Massy, Tilman B. Drüeke
Kidney International (2022) Vol. 101, Iss. 6, pp. 1100-1102
Closed Access | Times Cited: 4
Future of Uremic Toxin Management
Raymond Vanholder, Evelien Snauwaert, Francis Verbeke, et al.
Toxins (2024) Vol. 16, Iss. 11, pp. 463-463
Open Access
Raymond Vanholder, Evelien Snauwaert, Francis Verbeke, et al.
Toxins (2024) Vol. 16, Iss. 11, pp. 463-463
Open Access
Acute perioperative alterations in metabolism: A pilot study using mass spectrometry–based metabolomics
Keri A. Seymour, Madison Strain, Allison E. Ashley‐Koch, et al.
Surgery (2024) Vol. 180, pp. 109055-109055
Closed Access
Keri A. Seymour, Madison Strain, Allison E. Ashley‐Koch, et al.
Surgery (2024) Vol. 180, pp. 109055-109055
Closed Access
Sepsis associated with sodium glucose co‐transporter 2 inhibitor in an elderly patient with chronic kidney disease
Takahiko Nagamine
Geriatrics and gerontology international/Geriatrics & gerontology international (2023) Vol. 23, Iss. 10, pp. 757-758
Closed Access | Times Cited: 1
Takahiko Nagamine
Geriatrics and gerontology international/Geriatrics & gerontology international (2023) Vol. 23, Iss. 10, pp. 757-758
Closed Access | Times Cited: 1
Acute kidney disease in mice is associated with early cardiovascular dysfunction
Pauline Caillard, Youssef Bennis, Cédric Boudot, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access
Pauline Caillard, Youssef Bennis, Cédric Boudot, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access
Rôle des toxines urémiques dans la genèse des complications de la maladie rénale chronique
Sophie Liabeuf, Tilman B. Drüeke, Ziad A. Massy
Bulletin de l Académie Nationale de Médecine (2023) Vol. 207, Iss. 3, pp. 238-246
Open Access
Sophie Liabeuf, Tilman B. Drüeke, Ziad A. Massy
Bulletin de l Académie Nationale de Médecine (2023) Vol. 207, Iss. 3, pp. 238-246
Open Access
New Strategies for the Reduction of Uremic Toxins: How Much More We Know
Maria Teresa Rocchetti
Toxins (2021) Vol. 13, Iss. 12, pp. 837-837
Open Access
Maria Teresa Rocchetti
Toxins (2021) Vol. 13, Iss. 12, pp. 837-837
Open Access
